Ocular Toxicity Associated with Tamoxifen Administration in Patients with Breast Cancer: A Systematic Review

Ocular Toxicity Associated with Tamoxifen Administration in Patients with Breast Cancer: A Systematic Review

Introduction: Tamoxifen (TAM), a selective Oestrogen Receptor (ER) modulator, is widely used for treating and preventing ER-positive Breast Cancer (BC). TAM, administered as an adjuvant therapy for hormone receptor-positive BC, reduces recurrence but can cause ocular toxicity, including retinal dege...

Full description

Saved in:
Bibliographic Details
Main Authors: Tejaswi Vadde, Neha Narayan, Amulya Varshini Banka, Shravani Divity, Yethindra Vityala
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-07-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
breast neoplasms
ocular changes
oestrogen receptor modulators
retinal diseases
Online Access:https://jcdr.net/articles/PDF/21180/78056_CE[Ra1]_F(SL)_QC(OM)_PF1(Rf_SS)_redo_PFA(IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items